US 100% Tariffs Loom Over Approved Chinese Innovative Drugs

 
• By Dexter Jie Yan
  
Chinese innovative drugs approved for marketing by the US FDA are facing potential 100% tariff rates. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip